Literature DB >> 8322783

Cholesterol: a renal risk factor in diabetic nephropathy?

H Mulec1, S A Johnsen, O Wiklund, S Björck.   

Abstract

In a prospective follow-up of 30 patients with type 1 diabetes and nephropathy, serum cholesterol, triglycerides, apolipoprotein Al and B, and lipoprotein(a) were determined to study their relationship to the rate of decline in glomerular filtration rate. The patients had proteinuria and advanced nephropathy with a mean +/- SD glomerular filtration rate of 39 mL/min/1.73 m2. The decline in glomerular filtration rate was determined during 2.5 +/- 0.5 years. High serum cholesterol, triglycerides, and apolipoprotein B were correlated to a more rapid deterioration in kidney function. The rate of decline in glomerular filtration rate was 1.0 +/- 2.5 mL/min/yr in the 10 patients with the lowest cholesterol level, compared with 4.5 +/- 3.2 mL/min/yr in the patients with the highest serum cholesterol (P = 0.015). The combined effect of the measured lipids, blood pressure, type of antihypertensive treatment, protein intake, proteinuria, and hemoglobin A1C on the rate of decline in glomerular filtration rate was assessed by multiple regression analysis. The measured factors together had a high explanatory power for the rate of decline in glomerular filtration rate. In this model, 73% of the variation in decline in glomerular filtration rate was explained by the measured variables (multiple r2 = 0.73). Low cholesterol and treatment with an angiotensin-converting enzyme inhibitor were the strongest predictors of a favorable renal prognosis. This suggests that hypercholesterolemia is an important risk factor for diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322783     DOI: 10.1016/s0272-6386(12)70186-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  26 in total

Review 1.  Lipids and diabetic nephropathy.

Authors:  Rey F Rosario; Sharma Prabhakar
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

Review 3.  Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?

Authors:  D Kees-Folts
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

4.  Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio.

Authors:  Satoshi Okumura; Masaki Sakakibara; Ryo Hayashida; Yasushi Jinno; Akihito Tanaka; Koji Okada; Mutsuharu Hayashi; Hideki Ishii; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2013-01-29       Impact factor: 2.037

Review 5.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 6.  PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Authors:  Anne Hiukka; Marianna Maranghi; Niina Matikainen; Marja-Riitta Taskinen
Journal:  Nat Rev Endocrinol       Date:  2010-06-22       Impact factor: 43.330

7.  Intensified inhibition of renin-angiotensin system: a way to improve renal protection?

Authors:  Paolo Cravedi; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

Review 8.  Treatment and impact of dyslipidemia in diabetic nephropathy.

Authors:  Tadashi Toyama; Miho Shimizu; Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-11-07       Impact factor: 2.801

9.  Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus.

Authors:  Yoshie Sasatomi; Hidetoshi Kaneoka; Yasuhiro Abe; Atunori Ishimura; Satoru Ogahara; Toshiaki Murata; Noriko Uesugi; Shigeo Takebayashi; Hiroshi Iwasaki; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

10.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.